{"title": "AYAHUASCA: Overview, Uses, Side Effects, Precautions, Interactions, Dosing and Reviews", "author": null, "url": "https://www.webmd.com/vitamins/ai/ingredientmono-1550/ayahuasca", "hostname": "webmd.com", "description": "Learn more about AYAHUASCA uses, effectiveness, possible side effects, interactions, dosage, user ratings and products that contain AYAHUASCA.", "sitename": "webmd.com", "date": "2005-01-01", "cleaned_text": "Y., Adel-Khalek, Gammaz H., Mohamed, M. F., and Watanabe, H. Central serotonin level-dependent changes in body temperature following administration of tryptophan to pargyline- and harmaline-pretreated rats. Gen Pharmacol 1997;28(3):405-409. View Abdel-Fattah, A. F., Matsumoto, K., Murakami, Y., Adel-Khalek, Gammaz H., Mohamed, M. F., and Watanabe, H. Central serotonin level-dependent changes in body temperature following administration of tryptophan to pargyline- and harmaline-pretreated Alves CL, Cury RG, Roster K, et al. Application of machine learning and complex network measures to an EEG dataset from ayahuasca experiments. PLoS One 2022;17(12):e0277257. View abstract. Alves CL, Cury RG, Roster K, et al. Application of machine learning and complex network measures to an EEG dataset from ayahuasca experiments. PLoS One 2022;17(12):e0277257. PC, Bogenschutz MP, Strassman RJ. Health status of ayahuasca users. Drug Test Anal. 2012 Jul-Aug;4(7-8):601-9. View abstract. Barbosa PC, Mizumoto S, Bogenschutz MP, Strassman RJ. Health status of ayahuasca Drug Jul-Aug;4(7-8):601-9. View abstract. Bayat Mokhtari M, Bayat Mokhtari M, Rodriguez BZ, Yen TY, Rodriguez ID. Syndrome of inappropriate antidiuretic hormone secretion following ayahuasca use in a satanic M, Bayat Mokhtari M, Rodriguez BZ, Yen TY, Rodriguez ID. Syndrome of inappropriate antidiuretic hormone secretion following ayahuasca use in a satanic ritual: case report. Cureus 2022;14(4):e24310. View abstract. Bergstrom, M., Westerberg, G., and Langstrom, 11C-harmine as a tracer for monoamine oxidase A (MAO-A): in vitro and in vivo Med Biol 1997;24(4):287-293. View abstract. Bergstrom, M., Westerberg, G., Langstrom, 11C-harmine as a tracer for monoamine oxidase A (MAO-A): in vitro and in vivo View abstract. Bouso JC, \u00d3, Sarris JJ, et al. Adverse effects of ayahuasca: Results from the Global Ayahuasca Survey. PLOS Glob 2022;2(11):e0000438. View abstract. Bouso JC, Andi\u00f3n \u00d3, Sarris JJ, et al. Adverse effects of ayahuasca: Results from the Global Ayahuasca Survey. PLOS Glob 2022;2(11):e0000438. View abstract. Breeksema Kuin Kamphuis J, van den Brink W, Vermetten E, Schoevers RA. Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic abstract. Breeksema JJ, Kuin BW, Kamphuis J, van den Brink W, Vermetten E, Schoevers RA. Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review. CS. Ayahuasca preparations and serotonin reuptake inhibitors: a potential combination for severe adverse interactions. J Psychoactive Drugs. 1998 Oct-Dec;30(4):367-9. View abstract. Callaway JC, Grob CS. Ayahuasca preparations and serotonin reuptake inhibitors: a potential combination for severe adverse interactions. J Psychoactive Drugs. 1998 Oct-Dec;30(4):367-9. View abstract. Callaway JC. Fast and slow metabolizers of Hoasca. J Psychoactive Drugs. 2005 Jun;37(2):157-61. View abstract. Callaway JC. Fast and slow metabolizers of Hoasca. J Psychoactive 2005 MA, PR, Sussulini A, Oliveira MGM. Effects of repeated ayahuasca administration on behaviour and c-Fos expression in male rats exposed to the open field. Behav Brain Res 2022;427:113878. View abstract. Daldegan-Bueno D, Favaro VM, Morais PR, Sussulini A, Oliveira MGM. Effects of repeated ayahuasca administration on behaviour and c-Fos expression in male rats exposed to the open field. Behav Brain Res 2022;427:113878. View abstract. de Sousa GM, de Oliveira Tavares VD, de Menezes Galv\u00e3o AC, et al. Moderators of ayahuasca's biological antidepressant action. Front Psychiatry 2022;13:1033816. View abstract. de Sousa GM, de Oliveira Tavares VD, de Menezes Galv\u00e3o AC, et al. Moderators of ayahuasca's biological antidepressant action. Front Psychiatry 2022;13:1033816. View abstract. Dos Santos RG, Balthazar FM, Bouso JC, Hallak JE. The current state of research on ayahuasca: A systematic review of human studies assessing psychiatric symptoms, neuropsychological functioning, and neuroimaging. J Psychopharmacol. 2016 Jun 10. pii: 0269881116652578. View abstract. Dos Santos RG, Balthazar FM, Bouso JC, Hallak JE. The current state of research on ayahuasca: A systematic review of human studies assessing psychiatric symptoms, neuropsychological functioning, and neuroimaging. J Psychopharmacol. 2016 Jun 10. pii: 0269881116652578. View abstract. Dos Santos RG, Grasa E, Valle M, et al. Pharmacology of ayahuasca administered in two repeated doses. Psychopharmacology (Berl). 2012 Feb;219(4):1039-53. View abstract. Dos Santos RG, Grasa E, Valle M, et al. Pharmacology of ayahuasca administered in two repeated doses. Psychopharmacology (Berl). Feb;219(4):1039-53. abstract. lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years. Ther Adv Psychopharmacol. 2016 Jun;6(3):193-213. lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years. Ther Adv Psychopharmacol. 2016 JM, et al. Ayahuasca Improves Self-perception of Speech Performance in Subjects With Social Anxiety Disorder: A Pilot, Proof-of-Concept, Randomized, Placebo-Controlled Trial. et al. Ayahuasca Improves Self-perception of Speech Performance in Subjects With Social Anxiety Disorder: A Pilot, Proof-of-Concept, Randomized, Placebo-Controlled Trial. Rocha JM, GN, et al. Effects of ayahuasca on the endocannabinoid system of healthy volunteers and in volunteers with social anxiety disorder: Results from two pilot, proof-of-concept, randomized, placebo-controlled trials. Rocha JM, Rossi GN, et al. Effects of ayahuasca on the endocannabinoid system of healthy volunteers and in volunteers with social anxiety disorder: Results from two pilot, proof-of-concept, randomized, placebo-controlled trials. Hum 2022;37(4):e2834. View abstract. M, Bouso et al. Autonomic, neuroendocrine, and immunological effects of ayahuasca: a comparative study with d-amphetamine. J Clin Psychopharmacol. 2011 Dec;31(6):717-26. View abstract. Dos Bouso JC, et al. Autonomic, neuroendocrine, and immunological effects of ayahuasca: a comparative study with d-amphetamine. J Clin Psychopharmacol. 2011 Dec;31(6):717-26. View abstract. dos Santos RG. A critical evaluation of reports associating ayahuasca with life-threatening adverse reactions. J Psychoactive Drugs. 2013 Apr-Jun;45(2):179-88. View abstract. dos Santos RG. A critical evaluation of reports associating ayahuasca with life-threatening adverse reactions. J Psychoactive Drugs. 2013 Apr-Jun;45(2):179-88. View abstract. dos Santos RG. Safety and side effects of ayahuasca in humans--an overview focusing on developmental toxicology. J Psychoactive Drugs. 2013 Jan-Mar;45(1):68-78. View abstract. dos Santos RG. Safety and side effects of ayahuasca in humans--an overview focusing on developmental toxicology. J Psychoactive Drugs. 2013 Jan-Mar;45(1):68-78. View abstract. Fuller, R. W., Wong, C. J., and Hemrick-Luecke, S. K. MD 240928 and harmaline: opposite selectivity in antagonism of the inactivation of types A and B monoamine oxidase by pargyline in mice. Life Sci 1986;38(5):409-412. View abstract. Fuller, R. W., Wong, C. J., and Hemrick-Luecke, S. K. MD 240928 and harmaline: opposite selectivity in antagonism of the inactivation of types A and B monoamine oxidase by pargyline in mice. Life Sci 1986;38(5):409-412. View abstract. Gerardy, J. Effect of moclobemide on rat brain monoamine oxidase View moclobemide on rat brain monoamine oxidase Maia LO, Carlini EA. Ayahuasca blocks ethanol preference in an animal model of dependence and shows no acute toxicity. J Ethnopharmacol 2022;285:114865. View abstract. Gianfratti B, Maia LO, Carlini EA. Ayahuasca blocks ethanol preference in an animal model of dependence and shows no acute toxicity. J Ethnopharmacol 2022;285:114865. View abstract. Giovannetti C, Garcia Arce S, Rush B, Mendive F. Pilot Evaluation of a Residential Drug Addiction Treatment Combining Traditional Amazonian Medicine, Ayahuasca and Psychotherapy on Depression and Anxiety. J Psychoactive Drugs. 2020;52(5):472-481. View abstract. Giovannetti C, Garcia Arce S, Rush B, Mendive F. Pilot Evaluation of a Residential Drug Addiction Treatment Combining Traditional Amazonian Medicine, Ayahuasca and Psychotherapy on Depression and Anxiety. J Psychoactive Drugs. 2020;52(5):472-481. View abstract. G\u00f3mez-Sousa M, Jim\u00e9nez-Garrido DF, Ona G, et al. Acute Psychological Adverse Reactions in First-Time Ritual Ayahuasca Users: A Prospective Case Series. 2021;41(2):163-171. View abstract. G\u00f3mez-Sousa M, Jim\u00e9nez-Garrido DF, Ona G, et al. Acute Psychological Adverse Reactions in First-Time Ritual Ayahuasca Users: A Prospective Case Series. J 2021;41(2):163-171. View abstract. Gonz\u00e1lez D, Cantillo J, P\u00e9rez I, et al. Therapeutic potential of ayahuasca in grief: a prospective, observational study. Psychopharmacology (Berl). 2020;237(4):1171-1182. View abstract. Gonz\u00e1lez D, Cantillo J, P\u00e9rez I, et al. Therapeutic potential of ayahuasca in grief: a prospective, observational study. Psychopharmacology (Berl). 2020;237(4):1171-1182. View abstract. Herraiz, T., Gonzalez, D., Ancin-Azpilicueta, C., Aran, V. J., and Guillen, H. beta-Carboline Peganum harmala and Food Toxicol 2010;48(3):839-845. View abstract. Herraiz, T., Gonzalez, D., Ancin-Azpilicueta, C., Aran, V. J., and Guillen, H. beta-Carboline Peganum harmala and Nomikos, G., P., Silvestrini, B., and Svensson, H. Effects of harmine on dopamine output and metabolism in rat striatum: role monoamine Nomikos, G., P., Silvestrini, B., and Svensson, H. Effects of harmine on dopamine output and metabolism in rat striatum: role Ona G, et al. Effects of ayahuasca on mental health and quality of life in na\u00efve users: A longitudinal and cross-sectional study combination. Sci Rep. 2020;10(1):4075. View abstract. Jim\u00e9nez-Garrido DF, G\u00f3mez-Sousa M, Ona G, et al. Effects of ayahuasca on mental health and quality of life in na\u00efve users: A longitudinal and cross-sectional study combination. Sci Rep. 2020;10(1):4075. View abstract. Kaasik H, Souza RCZ, Zandonadi FS, T\u00f3foli LF, Sussulini A. Chemical Composition of Traditional and Analog Ayahuasca. J Psychoactive Drugs. 2021;53(1):65-75. View Zandonadi FS, T\u00f3foli LF, Sussulini A. Chemical Composition of Traditional and Analog Ayahuasca. J Psychoactive Drugs. 2021;53(1):65-75. View abstract. Kawanishi, K., Hashimoto, Y., Fujiwara, M., Kataoka, Y., and Ueki, S. Pharmacological characteristics of abnormal behavior induced by harmine with special reference to tremor in mice. J Pharmacobiodyn 1981;4(7):520-527. View abstract. Kawanishi, K., Hashimoto, Y., Fujiwara, M., Kataoka, Y., and Ueki, S. Pharmacological characteristics of abnormal behavior induced by harmine with special reference to tremor in mice. J Pharmacobiodyn 1981;4(7):520-527. View abstract. Kohek M, Ona G, van Elk M, et al. Ayahuasca and public health II: Health status in a large sample of ayahuasca-ceremony participants in the Netherlands. J Psychoactive Drugs 2022. View abstract. Kohek M, Ona G, van Elk M, et al. Ayahuasca and public health II: Health status in a large sample of ayahuasca-ceremony participants in the Netherlands. J Psychoactive Drugs 2022. View abstract. Ledwos N, Rosenblat JD, Blumberger DM, et al. A critical appraisal of evidence on the efficacy and safety of serotonergic psychedelic drugs as emerging antidepressants: Mind the evidence gap. Psychopharmacol 2022;42(6):581-588. View abstract. Ledwos N, Rosenblat JD, Blumberger DM, et al. A critical appraisal of evidence on the efficacy and safety of serotonergic psychedelic drugs as emerging antidepressants: Mind the evidence gap. J Clin Psychopharmacol 2022;42(6):581-588. View abstract. Lesiak AD, Musah RA. Application of ambient ionization high resolution mass spectrometry to determination of the botanical provenance of the constituents of psychoactive drug mixtures. Forensic Sci Int. 2016 Sep;266:271-80. View abstract. Lesiak AD, Musah RA. Application of ambient ionization high resolution mass spectrometry to determination of the botanical provenance of the constituents of psychoactive drug mixtures. Forensic Sci Int. 2016 Sep;266:271-80. View abstract. McIlhenny EH, Riba J, Barbanoj MJ, Strassman R, Barker SA. Methodology for and the determination of the major constituents and metabolites of the Amazonian botanical medicine ayahuasca in human urine. Biomed Chromatogr. 2011 MJ, Strassman R, Barker SA. Methodology for and the determination of the major constituents and metabolites of the Amazonian botanical medicine ayahuasca in human urine. Biomed Chromatogr. 2011 Sep;25(9):970-84. View abstract. Mello SM, Soubhia PC, Silveira G, et al. Effect of ritualistic consumption of ayahuasca on hepatic function in chronic users. J Psychoactive Drugs. 2019;51(1):3-11. View abstract. Mello SM, Soubhia PC, Silveira G, et al. Effect of ritualistic consumption of ayahuasca on hepatic function in chronic users. J Psychoactive Drugs. 2019;51(1):3-11. View abstract. Murphy-Beiner A, Soar K. Ayahuasca's 'afterglow': improved mindfulness and cognitive flexibility in ayahuasca drinkers. Psychopharmacology (Berl). 2020;237(4):1161-1169. View abstract. Murphy-Beiner A, Soar K. Ayahuasca's 'afterglow': improved mindfulness and cognitive flexibility in ayahuasca drinkers. Psychopharmacology (Berl). 2020;237(4):1161-1169. View RF, Hallak Ayahuasca and its Alkaloids on Drug Dependence: A Systematic Literature Review of Quantitative Studies in Animals and Humans. J Psychoactive Drugs. 2016 Jul-Aug;48(3):195-205. View abstract. Nunes AA, Os\u00f3rio RF, Hallak Ayahuasca and its Alkaloids on Drug Dependence: A Systematic Literature Review of Quantitative Studies in Animals and Humans. J Psychoactive Drugs. 2016 Jul-Aug;48(3):195-205. View abstract. Ona G, Kohek M, Massaguer T, et al. Ayahuasca and public health: Health status, psychosocial well-being, lifestyle, and coping strategies in a large sample of ritual ayahuasca users. J Psychoactive Drugs. 2019;51(2):135-145. View abstract. Ona G, Kohek M, Massaguer T, et al. Ayahuasca and public health: Health status, psychosocial well-being, lifestyle, and coping strategies in a large sample of ritual ayahuasca users. J Psychoactive Drugs. 2019;51(2):135-145. View abstract. Os\u00f3rio Fde L, Sanches RF, Macedo LR, et al. Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report. Rev Bras Psiquiatr. 2015 Os\u00f3rio Fde L, Sanches RF, Macedo LR, et al. Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report. Rev Bras Psiquiatr. 2015 Jan-Mar;37(1):13-20. View abstract. Palhano-Fontes F, Barreto D, Onias H, et al. Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: Palhano-Fontes F, Barreto D, Onias H, et al. Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: RF, Grau-L\u00f3pez L, Ros-Cucurull E, et al. Psychosis induced by abuse of ayahuasca: a case report. Rev Colomb Psiquiatr abstract. Palma-\u00c1lvarez RF, Grau-L\u00f3pez L, Ros-Cucurull E, et al. Psychosis induced by abuse of ayahuasca: a case report. Rev Colomb Psiquiatr (Engl Ed). 2021;50(1):43-46. Sarris J, Barbosa PCR, Chenhall R. Changes in mental health, wellbeing and personality following ayahuasca consumption: Results of a naturalistic longitudinal study. Front Pharmacol 2022;13:884703. View abstract. Perkins D, Pagni BA, Sarris J, Barbosa PCR, Chenhall R. Changes in mental health, wellbeing and personality following ayahuasca consumption: Results of a naturalistic longitudinal study. Front Pharmacol 2022;13:884703. View abstract. Pomilio AB, Vitale M, G\u00f3mez R, V\u00e1zquez G. Ayahoasca: an experimental psychosis that mirrors the transmethylation hypothesis of schizophrenia. J Ethnopharmacol. 1999 Apr;65(1):29-51. View abstract. Pomilio AB, Vitale Cetkovich-Bakmas M, G\u00f3mez R, V\u00e1zquez G. Ayahoasca: an experimental psychosis that mirrors the transmethylation hypothesis of schizophrenia. J Ethnopharmacol. 1999 Apr;65(1):29-51. View abstract. Riba J, Rodr\u00edguez-Fornells A, Urbano G, et al. Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers. Psychopharmacology (Berl). 2001 Feb;154(1):85-95. View abstract. Riba J, Rodr\u00edguez-Fornells A, Urbano G, et al. Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers. Psychopharmacology (Berl). 2001 abstract. Rocha JM, Rossi GN, de Lima Os\u00f3rio F, et al. Effects of Ayahuasca on the Recognition of Facial Expressions of Emotions in Naive Healthy Volunteers: A Pilot, Proof-of-Concept, Randomized Controlled Trial. JM, Rossi GN, de Lima Os\u00f3rio F, et al. Effects of Ayahuasca on the Recognition of Facial Expressions of Emotions in Naive Healthy Volunteers: A Pilot, Proof-of-Concept, Randomized Controlled Trial. Adverse Effects Administration in the Clinical Setting. J Clin Adverse Effects Administration in the Clinical Setting. J Clin Psychopharmacol 2022;42(3):321-324. View abstract. Rosenblat JD, Husain MI, Lee Y, et al. The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder. Can J Psychiatry 2023;68(1):5-21. View abstract. Rosenblat JD, Husain MI, Lee Y, et al. The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder. Can J Psychiatry 2023;68(1):5-21. View abstract. Sacher, J., Houle, S., Parkes, J., Rusjan, P., Sagrati, S., Wilson, A. A., and Meyer, J. H. Monoamine oxidase A inhibitor occupancy during treatment of major depressive episodes with moclobemide or St. John's wort: an [11C]-harmine PET study. J Neurosci Sacher, J., Houle, S., Parkes, J., Rusjan, P., Sagrati, S., Wilson, A. A., and Meyer, J. H. Monoamine oxidase A inhibitor occupancy during treatment of major depressive episodes with moclobemide or St. John's wort: an [11C]-harmine PET study. J Psychiatry Neurosci 2011;36(6):375-382. View abstract. Sanches RF, de Lima Os\u00f3rio F, Dos Santos RG, et al. Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression: A SPECT Study. J Clin Psychopharmacol. 2016 Feb;36(1):77-81. View abstract. Sanches RF, de Lima Os\u00f3rio F, Dos Santos RG, et al. Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression: A SPECT Study. J Clin Psychopharmacol. 2016 Feb;36(1):77-81. View abstract. Schenberg EE. Ayahuasca and cancer treatment. SAGE Open Med. 2013 Oct 18;1:2050312113508389. View abstract. Schenberg EE. Ayahuasca and cancer treatment. SAGE Open Med. 2013 Oct 18;1:2050312113508389. View abstract. Simonsson O, Bouso JC, Kurth F, et al. Preliminary evidence of links between ayahuasca use and the corpus callosum. Front Psychiatry 2022;13:1002455. View abstract. Simonsson O, Bouso JC, Kurth F, et al. Preliminary evidence of links between ayahuasca use and the corpus callosum. Front Psychiatry 2022;13:1002455. View abstract. Sklerov J, Levine B, Moore KA, King T, Fowler D. A fatal intoxication following the ingestion of 5-methoxy-N,N-dimethyltryptamine in an ayahuasca preparation. J Anal Toxicol. 2005 Nov-Dec;29(8):838-41. View abstract. Sklerov J, Levine B, Moore KA, King T, Fowler D. A fatal intoxication following the ingestion of 5-methoxy-N,N-dimethyltryptamine in an ayahuasca preparation. J Anal Toxicol. 2005 Nov-Dec;29(8):838-41. View abstract. Szmulewicz AG, Valerio MP, Smith JM. Switch to mania after ayahuasca consumption in a man with bipolar disorder: a case report. Int J Bipolar Disord. 2015 Feb 24;3:4. View abstract. Szmulewicz AG, Valerio MP, Smith JM. Switch to mania after ayahuasca consumption in a man with bipolar disorder: a case report. Int J Bipolar Disord. 2015 Feb 24;3:4. View abstract. Thomas G, Lucas P, Capler NR, Tupper KW, Martin G. Ayahuasca-assisted therapy for addiction: results from a preliminary observational study in Canada. Curr Drug Abuse Rev. 2013 Mar;6(1):30-42. View abstract. Thomas G, Lucas P, Capler NR, Tupper KW, Martin G. Ayahuasca-assisted therapy for addiction: results from a preliminary observational study in Canada. Curr Drug Abuse Rev. 2013 Mar;6(1):30-42. View abstract. Uthaug MV, Mason NL, Toennes SW, et al. A placebo-controlled study of the effects of ayahuasca, set and setting on mental health of participants in ayahuasca group retreats. Psychopharmacology (Berl). 2021 Jul;238(7):1899-1910. View abstract. Mason NL, Toennes SW, et al. A placebo-controlled study of the effects of ayahuasca, set and setting on mental health of participants in ayahuasca group retreats. Psychopharmacology (Berl). 2021 KPC, et al. Sub-acute and long-term effects of ayahuasca on affect and cognitive thinking style and their association with ego dissolution. Psychopharmacology (Berl). 2018;235(10):2979-2989. View abstract. Uthaug MV, van Oorsouw K, KPC, et al. Sub-acute and long-term effects of ayahuasca on affect and cognitive thinking style and their association with ego dissolution. Psychopharmacology (Berl). 2018;235(10):2979-2989. View abstract. Yritia M, Riba J, et al. Determination of N,N-dimethyltryptamine and beta-carboline alkaloids in human plasma following oral administration of Ayahuasca. J Chromatogr B Analyt Technol Biomed Life Sci. 5;779(2):271-81. View abstract. Yritia M, Riba J, Ortu\u00f1o J, et al. Determination of N,N-dimethyltryptamine and beta-carboline alkaloids in human plasma following oral administration of Ayahuasca. J Chromatogr B Analyt Technol Biomed impact of ayahuasca on suicidality: Results from a randomized controlled trial. impact of ayahuasca on suicidality: Results from a randomized controlled trial. Front Pharmacol. 2019;10:1325. View abstract. Zeifman RJ, Singhal N, Dos Santos RG, et al. Rapid and sustained decreases in suicidality following a single dose of ayahuasca among individuals with recurrent major depressive disorder: results from an open-label trial. Psychopharmacology (Berl). Zeifman RJ, Singhal N, Dos Santos RG, et al. Rapid and sustained decreases in suicidality following a single dose of ayahuasca among individuals with recurrent major depressive disorder: results from an open-label trial. Psychopharmacology (Berl). 2021;238(2):453-459. View abstract. Zhao, T., He, Y. Q., Wang, J., Ding, K. M., Wang, C. H., and Wang, Z. T. Inhibition of human cytochrome P450 Phytother Res 2011;25(11):1671-1677. View abstract. Zhao, T., He, Y. Q., Wang, J., Ding, K. M., Wang, C. H., and Wang, Z. T. Inhibition of human cytochrome P450 Phytother Res 2011;25(11):1671-1677. View abstract. "}